Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares CANF
$3.58
+5.29%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-08-17 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-08-12 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-08-03 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-07-20 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-07-14 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-07-06 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-07-01 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-06-26 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-06-22 | View → |
| 6-K | FORM 6-K | 2026-06-17 | View → |
| 4 | Insider transaction | 2026-06-08 | View → |
| 4 | Insider transaction | 2026-06-08 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-06-04 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-06-02 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-28 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-18 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-13 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-04-30 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-04-23 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-03-30 | View → |
| 20-F | ANNUAL REPORT | 2026-03-26 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-03-26 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-03-17 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-03-10 | View → |
| 6-K | CURRENT REPORT | 2026-03-05 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-03-04 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-03-03 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-02-17 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-02-09 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-02-05 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-27 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-20 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-16 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-29 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-23 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-16 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-21 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-20 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-18 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-10 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $3.58
- Market Cap
- $7.28 million
- 52-Week Range
- $2.56 – $21.00
- Average Volume
- 93K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.